Toronto Dominion Bank
RARE icon

Toronto Dominion Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History

Toronto Dominion Bank’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,500
Closed -$863K – 2356
2025
Q4 		$863K Buy
+37,500
New +$1.23M ﹤0.01% 1291

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Toronto Dominion Bank's RARE Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Ultragenyx Pharmaceutical (RARE) stake by 99% in Q1 2026, selling an estimated $710K and leaving 162 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Toronto Dominion Bank first reported a position in RARE in Q4 2019 and has held it in 5 quarters since. The position peaked at $816K in Q3 2022. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Toronto Dominion Bank held 162 shares of Ultragenyx Pharmaceutical worth $3.39K as of Q1 2026.
  • Toronto Dominion Bank sold 31,538 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $710K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1986 holding.
  • Toronto Dominion Bank first reported a position in Ultragenyx Pharmaceutical in Q4 2019 and has held it in 5 quarters since.
  • Toronto Dominion Bank's Ultragenyx Pharmaceutical position peaked at $816K in Q3 2022.
  • 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.